Christoph U. Correll

Psychiatry and Mental health · 2009–2022

A researcher in the Science corpus: 15 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Psychiatry and Mental health — 132 citations into it
• Cellular and Molecular Neuroscience — 6 citations into it

Whom Christoph U. Correll trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Marc A. F. De Hert
2. S. Leucht
3. G. Moneta
4. David Moher
5. B. Kirkpatrick
6. J. Coyle
7. Davy Vancampfort
8. Andrea Cipriani

Who trusts Christoph U. Correll overall

1. Davy Vancampfort
2. Marc A. F. De Hert

Papers from Christoph U. Correll's perspective

Ordered by how strongly the researchers Christoph U. Correll trusts endorse each paper. Same corpus, a different order for every researcher.

1. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. (Archives of General Psychiatry)
2. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American… (Circulation)
3. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of… (European psychiatry)
4. Physical health monitoring of patients with schizophrenia. (American Journal of Psychiatry)
5. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. (Schizophrenia Research)
6. Schizophrenia and increased risks of cardiovascular disease. (American Heart Journal)
7. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. (New England Journal of Medicine)
8. Cardiometabolic Risk of Second-Generation Antipsychotics During First-Time Use in Children and Adolescents (Journal of the American Medical Association (JAMA))
9. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (New England Journal of Medicine)
10. Are mood disorders and obesity related? A review for the mental health professional. (Journal of Clinical Psychiatry)

Their papers

• How mental health care should change as a consequence of the COVID-19 pandemic (2020) — 1,286 citations
• Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors (2022) — 601 citations
• Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies (2021) — 3,026 citations
• Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment (2020) — 668 citations
• The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. (2019) — 1,227 citations
• Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression (2018) — 714 citations
• Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls (2017) — 1,527 citations
• Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016) — 599 citations
• Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (2015) — 777 citations
• Comprehensive Versus Usual Community Care For First Episode Psychosis: Two-Year Outcomes From The NIMH RAISE Early Treatment Program (2015) — 727 citations
• Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015) — 1,159 citations
• Metabolic and cardiovascular adverse effects associated with antipsychotic drugs (2012) — 1,054 citations
• Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) — 2,329 citations
• Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level (2011) — 854 citations
• Cardiometabolic Risk of Second-Generation Antipsychotics During First-Time Use in Children and Adolescents (2009) — 990 citations